Privia Health price target raised to $27 from $24 at Truist
The Fly

Privia Health price target raised to $27 from $24 at Truist

Truist raised the firm’s price target on Privia Health (PRVA) to $27 from $24 and keeps a Buy rating on the shares after its Q3 earnings beat. The company has had record new provider signings year-to-date, which gives the management great visibility heading into 2025, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App